SCHEMBL30095652

SCHEMBL30095652

C=C(C)c1ncnc2ccsc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 7/20 0.54
ADORA2B P29275 2/20 0.54
AXL P30530 1/20 0.52
MKNK1 Q9BUB5 1/20 0.52
MKNK2 Q9HBH9 1/20 0.52
HTR2C P28335 1/20 0.41
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
PIP4K2C Q8TBX8 1/20 0.39
IRAK4 Q9NWZ3 1/20 0.39
EGFR P00533 2/20 0.37
FADS1 O60427 1/20 0.37
PDPK1 O15530 1/20 0.37
PARP1 P09874 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14074698 0.84 ADORA2A (0.60) ADORA2AADORA2BAXLMKNK1MKNK2
SCHEMBL2881001 0.78 ADORA2A (0.57) ADORA2AADORA2BAXLMKNK1MKNK2
SCHEMBL29494878 0.76 ADORA2A (0.56) ADORA2AADORA2BAXLMKNK1MKNK2
SCHEMBL3661823 0.76 ADORA2A (0.56) ADORA2AADORA2BAXLMKNK1MKNK2
SCHEMBL14074693 0.76 ADORA2A (0.56) ADORA2AADORA2BAXLMKNK1MKNK2
SCHEMBL24322141 0.73 AXL (0.38) ADORA2AADORA2BAXLMKNK1MKNK2
SCHEMBL424626 0.72 AXL (0.59) ADORA2AADORA2BAXLMKNK1MKNK2
SCHEMBL6642089 0.72 AXL (0.59) ADORA2AADORA2BAXLMKNK1MKNK2
SCHEMBL30095858 0.71 ADORA2A (0.47) ADORA2AADORA2BAXLMKNK1MKNK2
SCHEMBL30095715 0.70 CHEK1 (0.52) HTR2CMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4346806-A2 IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE Biocryst Pharmaceuticals, Inc. (US) 2024-04-10 EP disclosed
WO-2022251188-A2 IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE BIOCRYST PHARMACEUTICALS, INC. (US) 2022-12-01 WO disclosed